Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-11-21

Clinical Trial Update: F-18 Altanserin PET Study of Patients Receiving Clozapine [NA]

View source ↗

Summary

This clinical trial update describes a PET imaging study using F-18 altanserin in patients receiving clozapine, including individuals with schizophrenia or schi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clozapine (Clozapine)
  • F-18 Altanserin (Altanserin)

Snippet

Sponsor: Seoul National University Bundang Hospital | Conditions: Schizophrenia, Schizoaffective Disorder | NA | Status: UNKNOWN